Odyssey Health (ODYY) Change in Receivables (2014 - 2024)

Odyssey Health (ODYY) reported Change in Receivables of -$268411.0 for Q1 2024, down 1954.95% sequentially from $14470.0 in Q4 2023.

Odyssey Health (ODYY) Change in Receivables (2014 - 2024) Analysis & Trends

Odyssey Health has disclosed Change in Receivables across 6 years of filings, most recently posting -$268411.0 for Q1 2024.

Quarterly Change in Receivables changed N/A year-over-year to -$268411.0 in Q1 2024, while the trailing twelve-month figure through Oct 2024 was -$268411.0 (down 1954.95% YoY) and the FY2024 annual result came in at -$253941.0, down 182.45% from the prior year.
Change in Receivables retreated to -$268411.0 in Q1 2024, from $14470.0 in the prior quarter.
Across five years, Change in Receivables topped out at $14470.0 in Q4 2023 and bottomed at -$268411.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	42.00 Mn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-444.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-13.00 Mn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	117.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	117.90 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-124.60 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-141.00 Mn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	123.50 Mn
10	Odyssey Health	-	-	-	-

Download Data